Kentucky Children’s Hospital is one of multiple sites around the nation participating in an experimental trial testing the safety and efficacy of a Biomarin pharmaceutical that reduces concentrations of phenylalanine in the bloodstream.
UK sent a delegation of executive, clinical and research leaders to join national thought-leaders and policymakers at the 2016 National Rx Drug Abuse and Heroin Summit.
High school freshmen in Kentucky are integrating physics, health, communication and technology through a collaborative, web-based project with scientists and students at the University of Kentucky.
Dr. Robert DiPaola, director of the Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences, has been named dean of the University of Kentucky College of Medicine.
More than 130 clinicians, researchers, policymakers and community members gathered at the 5th Annual ATRN Health Summit to share expertise, resources and facilitate collaboration.
The University of Kentucky and University of Alabama at Birmingham are partners on a $2.9 million, five-year National Institute on Aging clinical study to explore how Metformin may benefit older adults who do not respond well to exercise.
UK College of Pharmacy announced a major outreach initiative aimed at training pharmacists across the state for the prescription use of naloxone, a medication used for the treatment of suspected opioid overdose.